Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients

Obesity Surgery

Volumn 15, Issue 4, 2005, Pages 510-516

  Mion, François ^a   Napoléon, Bertrand ^a   Roman, Sabine ^a   Malvoisin, Etienne ^a   Trepo, Frédérique ^a   Pujol, Bertrand ^a   Lefort, Christine ^a   Bory, Roger Michel ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Gastric emptying; Ghrelin; Human; Intragastric balloon; Obesity

Indexed keywords

ADIPONECTIN; GHRELIN; LEPTIN;

ADULT; ARTICLE; BALLOON; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; SATIETY; STOMACH EMPTYING; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GASTRIC BALLOON; GASTRIC EMPTYING; GASTROPLASTY; HUMANS; MALE; MIDDLE AGED; OBESITY; PEPTIDE HORMONES; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 18044393599     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892053723411     Document Type: Article

References (31)

1. Totte E, Hendrickx L, Pauwels M et al. Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obes Surg 2001; 11: 519-23.
2. Hodson RM, Zacharoulis D, Goutzamani E et al. Management of obesity with the new intragastric balloon. Obes Surg 2001; 11: 327-9.
3. Roman S, Napoléon B, Mion F et al. Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg 2004; 14: 539-44.
4. Sallet JA, Marchesini JB, Paiva DS et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004; 14: 991-8.
5. Busetto L, Segato G, de Luca M et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case control study. Obes Surg 2004; 14: 671-6.
6. Doldi SB, Micheletto G, Perrini MN et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg 2002; 12: 583-7.
7. Ghoos YF, Maes BD, Geypens BJ et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 1640-7.
8. Kolotkin RL, Crosby RD, Kosloski KD et al. Development of a brief measure to assess quality of life in obesity. Obes Res 2001; 9: 102-11.
9. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; i: 198-9.
10. Boyle TM, Agus SG, Bauer JJ. Small intestinal obstruction secondary to obturation by a Garren gastric bubble. Am J Gastroenterol 1987; 82: 51-3.
11. Ulicny KS Jr, Goldberg SJ, Harper WJ et al. Surgical complications of the Garren-Edwards Gastric Bubble. Surg Gynecol Obstet 1988; 166: 535-40.
12. Schapiro M, Benjamin S, Blackburn G et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987. Gastrointest Endosc 1987; 33: 323-7.
13. Geliebter A, Hashim SA. Gastric capacity in normal, obese, and bulimic women. Physiol Behav 2001; 74: 743-6.
14. Verdich C, Madsen JL, Toubro S, et al. Effect of obesity and major weight reduction on gastric emptying. Int J Obes 2000; 24: 899-905.
15. Glasbrenner B, Pieramico O, Brecht-Krauss D et al. Gastric emptying of solids and liquids in obesity. Clin Investig 1993; 71: 542-6.
16. Velchik MG, Kramer FM, Stunkard AJ et al. Effect of the Garren-Edwards gastric bubble on gastric emptying. J Nucl Med 1989; 30: 692-6.
17. Lepsien K, Nustede R, Schafmayer A et al. Does the stomach balloon modify the function of the esophagus and lower esophageal sphincter, stomach emptying and release of gastrointestinal peptides? Z Gastroenterol 1989; 27: 247-53.
18. Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004; 134: 295-8.
19. Infanger D, Baldinger R, Branson R et al. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects. Obes Surg 2003; 13: 879-88.
20. Monzillo LU, Hamdy O, Horton ES et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003; 11: 1048-54.
21. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
22. Yang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-9.
23. Calvani M, Scarfone A, Granato L et al. Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 2004; 53: 939-47.
24. Valsamakis G, McTernan Pg P, Chetty R et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53: 430-4.
25. Druce MR, Small CJ, Bloom SR. Gut peptides regulating satiety. Endocrinology 2004; 145: 2660-5.
26. Hansen TK, Dall R, Hosoda H et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol 2002; 56: 203-6.
27. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
28. English PJ, Ghatei MA, Malik IA et al. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002; 87: 2984-7.
29. Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 2003; 88: 2999-3002.
30. Erdmann J, Lippl F, Schusdziarra V. Differential effect of protein and fat on plasma ghrelin levels in man. Regul Pept 2003; 116: 101-7.
31. Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology 1990; 99: 362-9.